The "Systemic Scleroderma Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com’s ...
The prognosis for patients diagnosed with scleroderma - an autoimmune disease characterized by fibrosis of the skin - is not typically a rosy one. With limited treatment options available, those ...
What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...
North Chicago biotech startup BLR Bio has received U.S. Food & Drug Administration Orphan Drug Designation for its investigational treatment for the rare disease systemic sclerosis. The drug, BLR-200, ...
Scleroderma is a chronic autoimmune disease of women. Over time, people living with scleroderma develop progressive and irreversible scarring. Scarring, called fibrosis, affects the lungs, heart and ...
Stephanie Daniels couldn't bend down to put on her socks. She noticed the first symptoms of scleroderma about 2 1/2 years ago while attending St. Edward's University in Austin. The disease's name ...
Please provide your email address to receive an email when new articles are posted on . Injections yielded significant improvements in visual analog scale pain and Quick-DASH score, as well as skin ...
For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and sometimes fatal illness stiffens and scars tissue in organs like the lungs, ...
As Bob Saget is remembered by his friends and co-stars, one memory that stands out is his commitment to finding a cure for scleroderma, a rare disease for which Saget was the most high-profile ...
MediciNova Inc (NASDAQ:MNOV) Wednesday announced it has received a Decision to Grant from the European Patent Office for a new patent which covers MN-001 (tipelukast) for the treatment of scleroderma ...
Grab your sneakers and get ready to hit the track and make a difference for those suffering from a debilitating disease. It's called the March for Scleroderma and it's happening at Sweet Briar College ...
LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc. (MNOV), a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange (Code ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results